Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RITUXIMAB-PVVR vs ROLAPITANT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RITUXIMAB-PVVR vs ROLAPITANT: Safety Overview

Metric RITUXIMAB-PVVR ROLAPITANT
Total FAERS Reports 4,210 873
Deaths Reported 415 252
Death Rate 9.9% 28.9%
Hospitalizations 966 155
Average Patient Age 60.4 yrs 61.4 yrs
% Female Patients 67.9% 57.5%
FDA Approval Date N/A Oct 25, 2017
Manufacturer N/A TerSera Therapeutics LLC
Route N/A ORAL
Marketing Status Prescription Prescription